LU76722A1 - - Google Patents

Info

Publication number
LU76722A1
LU76722A1 LU76722A LU76722A LU76722A1 LU 76722 A1 LU76722 A1 LU 76722A1 LU 76722 A LU76722 A LU 76722A LU 76722 A LU76722 A LU 76722A LU 76722 A1 LU76722 A1 LU 76722A1
Authority
LU
Luxembourg
Application number
LU76722A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/748,851 external-priority patent/US4082751A/en
Application filed filed Critical
Publication of LU76722A1 publication Critical patent/LU76722A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
LU76722A 1976-02-13 1977-02-08 LU76722A1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65778776A 1976-02-13 1976-02-13
US05/748,851 US4082751A (en) 1976-02-13 1976-12-08 Therapeutic agents

Publications (1)

Publication Number Publication Date
LU76722A1 true LU76722A1 (da) 1977-08-18

Family

ID=27097492

Family Applications (1)

Application Number Title Priority Date Filing Date
LU76722A LU76722A1 (da) 1976-02-13 1977-02-08

Country Status (14)

Country Link
JP (1) JPS52118481A (da)
AU (1) AU508970B2 (da)
CA (1) CA1083152A (da)
CH (1) CH635339A5 (da)
DE (1) DE2705609A1 (da)
DK (1) DK149044C (da)
FI (1) FI62533C (da)
FR (1) FR2340943A1 (da)
GB (1) GB1541351A (da)
IE (1) IE44603B1 (da)
LU (1) LU76722A1 (da)
NL (1) NL173055C (da)
SE (1) SE433494B (da)
YU (1) YU41567B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419357A (en) * 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones
CN101747282A (zh) * 2008-12-10 2010-06-23 上海特化医药科技有限公司 一类含有嘧啶酮苯基的化合物、其药物组合物及其制备方法和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883653A (en) * 1972-10-24 1975-05-13 Pfizer Method of preventing asthmatic symptoms

Also Published As

Publication number Publication date
FI62533C (fi) 1983-01-10
YU35477A (en) 1982-10-31
SE7701552L (sv) 1977-09-23
DE2705609A1 (de) 1977-08-25
CH635339A5 (en) 1983-03-31
SE433494B (sv) 1984-05-28
IE44603L (en) 1977-08-13
FR2340943A1 (fr) 1977-09-09
NL173055B (nl) 1983-07-01
DE2705609C2 (da) 1988-12-15
NL173055C (nl) 1983-12-01
JPS52118481A (en) 1977-10-04
FR2340943B1 (da) 1981-01-09
DK149044C (da) 1986-06-02
NL7701483A (nl) 1977-08-16
GB1541351A (en) 1979-02-28
FI62533B (fi) 1982-09-30
DK149044B (da) 1985-12-30
DK57377A (da) 1977-08-14
IE44603B1 (en) 1982-01-27
CA1083152A (en) 1980-08-05
JPS6139947B2 (da) 1986-09-06
AU2189577A (en) 1978-08-10
FI770427A (da) 1977-08-14
YU41567B (en) 1987-10-31
AU508970B2 (en) 1980-04-17

Similar Documents

Publication Publication Date Title
FR2340943B1 (da)
CS178381B1 (da)
CS175315B1 (da)
CS175505B1 (da)
CS175525B1 (da)
CH606681A5 (da)
DD126519A6 (da)
CH596061A5 (da)
CH609391A5 (da)
CH596920A5 (da)
CH597926A5 (da)
CH598353A5 (da)
CH598430A5 (da)
CH601724A5 (da)
CH602021A5 (da)
CH602320A5 (da)
CH602383A5 (da)
CH602947A5 (da)
CH603107A5 (da)
CH603249A5 (da)
CH603281A5 (da)
CH604962A5 (da)
CH612148A5 (da)
CH606631A5 (da)
DD125608A1 (da)